The inflammatory response.

Damaged or stressed cells release a class of signals known as damage-associated molecular patterns, or DAMPs. The signals reach nearby immune cells within seconds, flagging the affected area as a place that needs attention. The response begins before any visible swelling appears.

The trigger is sensitive by design. The body cannot afford to wait for confirmation that something is wrong. Even minor mechanical or chemical stress can initiate the cascade, which is part of why the system is so easily set off and why most of those activations resolve quietly on their own.

In the acute phase, blood vessels at the site dilate, become more permeable, and let plasma and immune cells leak into the surrounding tissue. Histamine, prostaglandins, and bradykinin amplify the local response. The classic signs (heat, redness, swelling, pain) are not the problem. They are the body delivering reinforcements.

This phase is short and intense, typically running over the first 0 to 72 hours. The local environment is rapidly recalibrated for cleanup and repair: more circulation, more permeability, more sensitivity. The discomfort that comes with it is biologically meaningful, and suppressing it too completely can interrupt the steps that follow.

Within hours of the trigger, neutrophils are the first immune cells to arrive in large numbers. They migrate toward the chemical gradient (chemotaxis), engulf debris and microbes (phagocytosis), and release additional signaling molecules as they go. They are the first wave, and they are short-lived.

Macrophages follow over the next one to three days. They continue the cleanup, but they also release growth factors and cytokines that begin the handoff from response to repair. Without the cellular response, the next phase cannot start. A healthy inflammatory response is the prerequisite to healing, not the obstacle to it.

Resolution is its own active process, not a passive fade-out. Specialized lipid mediators (resolvins, protectins, and maresins, collectively known as specialized pro-resolving mediators) signal the immune system to stand down. Pro-inflammatory neutrophils undergo apoptosis and are cleared. The site cools.

This phase is as biologically important as the acute response itself. A response that cannot resolve does not return to baseline. It lingers. The shift from inflammation to repair depends on this off-switch firing on time, which is part of why resolution has become one of the most active areas of inflammation research over the past two decades.

When resolution fails, acute becomes chronic. Low-grade inflammation persists at a tissue level without obvious symptoms, and the immune system remains partially activated for months or years. This pattern is increasingly associated with a long list of modern degenerative conditions in the published literature, though the causal direction is still being unpacked.

Persistent low-grade inflammation drives oxidative stress, alters metabolism, and changes how tissue is remodeled. The drivers (sustained psychological stress, poor sleep, ultra-processed diet, sedentary behavior, ongoing low-level injury) are largely modifiable. The chronic state is where most of the damage commonly attributed to "inflammation" actually accrues.

Different phases of the response respond to different inputs. The acute phase generally does not need to be muted. The cellular phase depends on adequate circulation and nutrients. Resolution depends on the substrates and conditions that allow specialized pro-resolving mediators to do their job. Knowing the phase is what makes ingredient choice meaningful.

Supporting a healthy inflammatory response is not the same as suppressing one. The difference matters most in the days and weeks after a real injury, when each phase has to be allowed to run before the next one can begin. The formulas are designed with this map in mind.